Skip to main content
. Author manuscript; available in PMC: 2021 Apr 27.
Published in final edited form as: Int J Cardiol. 2019 Mar 22;290:119–124. doi: 10.1016/j.ijcard.2019.03.040

Table 2.

Hazard ratios (95% confidence intervals) of mortality by current serum sodium level (mmol/L) in 50,932 participants with heart failure with preserved ejection fraction (HFpEF)

Short-term (30-day) mortality
115.00–133.99 134.00–137.00 137.01–140.99 141.00–142.99 143.00–175.00 p trend
Person Observations 7,318 20,895 29,928 14,711 9,525
Deaths 320 424 419 223 403
Person-Observation-years 261.25 852.89 1,294.66 655.97 411.11
Deaths per 100 POYs 122.49 49.71 32.36 34.00 98.03
Crude model 3.37 (2.85–3.99) 1.50 (1.29–1.74) 1.00 (ref) 1.03 (0.85–1.23) 2.49 (2.12–2.92) <0.0001
Age adjusted model 3.45 (2.92–4.07) 1.54 (1.32–1.79) 1.00 (ref) 0.99 (0.83–1.19) 2.35 (2.00–2.75) <0.0001
Multivariable modelǂ 2.96 (2.48–3.53) 1.47 (1.25–1.71) 1.00 (ref) 1.02 (0.85–1.24) 2.46 (2.08–2.90) <0.0001
Long-term (>30 day) mortality
Person Observations 51,865 179,463 272,156 137,405 85,410
Deaths 3,371 7,189 8,767 4,538 4,579
Person-Observation-years 8,838.89 39,633.90 70,704.47 38,380.01 23,460.67
Deaths per 100 POYs 38.14 18.14 12.40 11.82 19.52
Crude model 2.79 (2.68–2.91) 1.43 (1.38–1.48) 1.00 (ref) 0.95 (0.92–0.99) 1.45 (1.39–1.50) <0.0001
Age adjusted model 2.90 (2.78–3.02) 1.48 (1.44–1.53) 1.00 (ref) 0.92 (0.88–0.95) 1.35 (1.30–1.40) <0.0001
Multivariable modelǂ 2.48 (2.38–2.60) 1.38 (1.34–1.43) 1.00 (ref) 0.95 (0.91–0.98) 1.40 (1.35–1.46) <0.0001

The 137.01–140.99 mmol/L is the reference serum sodium category. Missing values are as follows: eGFR = 780, serum potassium=40, race=2,883. POY= person-observation years.

ǂ

Adjusted for age, sex, race, body mass index, estimated glomerular filtration rate, serum potassium, hypertension, hyperlipidemia, coronary artery disease, atrial fibrillation, diabetes mellitus type II, chronic obstructive pulmonary disease, anemia, angiotensin converting enzyme inhibitor/angiotensin receptor blocker prescription, beta blocker prescription, and calcium channel blocker prescription.